Valens GroWorks Corp., a licensed, vertically integrated provider of cannabis products and services focused on various proprietary extraction methodologies, distillation, cannabinoid isolation and purification, as well as associated quality testing is pleased to announce it has established an expanded research collaboration agreement with Thermo Fisher Scientific.
As part of the collaboration, Valens will utilize Thermo Fisher’s instruments and consumables to develop and validate analytical methods for the study of cannabis. The findings of this collaboration will be co-promoted through application notes, publication of peer-reviewed articles, conference presentations, and webinars.
“We are excited to expand our partnership with Thermo Fisher Scientific and capitalize upon our mutual interests to strengthen industry testing standards and increase patient safety,” says Tyler Robson, CEO of Valens GroWorks. “This research collaboration showcases the level of expertise of our scientific personnel and their drive to lead the industry in the analysis of cannabis. Our ISO 17025 accredited laboratory combined with the resources and scientific experience available from Thermo Fisher puts us in a great position to execute on our initiatives in the analytical testing space.”
“We’re committed to providing a one stop solution for cannabis safety testing across Canada and advancing plant research. Our collaboration with Valens will allow us to improve workflows and validate methods,” says Keith Bisogno, Thermo Fisher Scientific Corporate Senior Director for market development, “With our comprehensive portfolio of analytical instruments and broad line of laboratory products Thermo Fisher can uniquely support Valens’ vision for its Centre of Excellence for Plant Based Science.”